Table 2 Summary of study characteristics included in analysis
Authors | Year of Publication | Procedures | Treatment/Control | UG | Treatment | Anesthesia | Method of extraction |
|---|---|---|---|---|---|---|---|
Abu Elyazed et al. [26] | 2019 | Open epigastic hernia repair | 30/30 | Y | Bilateral 20 ml 0.25% bupivacaine Sham block (1 ml NS) | General | Text Table |
Aksu et al. [27] | 2019 | Breast surgery | 25/25 | Y | Single-shot 20 ml 0.25% bupivacaine No block | General | Text Table |
Ciftci et al. [28] | 2019 | Video assisted thoracic surgery | 30/30 | Y | Single-shot 20 ml 0.25% bupivacaine No block | General | Text Table |
Gurkan et al. [29] | 2018 | Breast cancer surgery | 25/25 | Y | Single-shot 20 ml 0.25% bupivacaine Sham block (NS) | General | Text Table |
Hamed et al. [30] | 2019 | Abdominal hysterectomy | 30/30 | Y | Bilateral 20 ml 0.5% bupivacaine Sham block (NS) | General | Text Table |
Krishna et al. [31] | 2018 | Cardiac surgery | 53/53 | Y | Bilateral 3 mg/kg 0.375% Ropivacaine No block | General | Text Table |
Oksuz et al. [32] | 2019 | Reduction mammoplasty | 21/22 | Y | Bilateral 20 ml 0.25% bupivacaine No block | General | Text |
Singh et al. [33] | 2019 | Radical mastectomy | 20/20 | Y | Single-shot 20 ml 0.5% bupivacaine No block | General | Text |
Singh et al. [34] | 2019 | Lumbar spine surgery | 20/20 | Y | Bilateral 20 ml 0.5% bupivacaine No block | General | Text Table |
Tulgar et al. [35] | 2019 | Laparoscopic Cholecystectomy | 20/20 | Y | Bilateral 20 ml 0.5% bupivacaine No block | General | Text Table |
Tulgar et al. [36] | 2018 | Orthopedic surgery | 20/20 | Y | Single-shot 20 ml 0.5% bupivacine No block | General | Text Table |
Tulgar et al. [37] | 2018 | Laparoscopic Cholecystectomy | 15/15 | Y | Bilateral 20 ml 0.375% bupivacaine No block | General | Text Table |
Yayik et al. [38] | 2019 | Lumbar decompression surgery | 30/30 | Y | Bilateral 20 ml 0.25% bupivacaine No block | General | Text Table |